AHEC Digital Library

AHEC librarians helping North Carolina health professionals in every county.

"Oncology" (117 records)

2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors

OVID
ACOG Committee Opinion No. 747: Gynecologic Issues in Children and Adolescent Cancer Patients and Survivors

OVID
Active expectancy as alternative to treatment for cervical intraepithelial neoplasia grade 2 in women aged 25 to 30 years: ExCIN2-a prospective clinical multicenter cohort study

American Journal of Obstetrics and Gynecology
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Elsevier
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer

New England Journal of Medicine
Adoptive T-cell therapy is a promising salvage approach for advanced or recurrent metastatic cervical cancer

No Pub/Vend Assigned
American Society of Clinical Oncology

American Society of Clinical Oncology
American Society of Pediatric Hematology/Oncology

American Society of Pediatric Hematology/Oncology
Antienetics: American Society of Clinical Oncolocy Clinical Practice Guideline Update

American Society of Clinical Oncology
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

No Pub/Vend Assigned
Association Between Fertility Treatment and Cancer Risk in Children

PubMed
Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials

American Board of Obstetrics and Gynecology
Bio Rxiv

Cold Spring Harbor Laboratory
BMC Cancer
(Full text available: 2001 - present)

BioMed Central
Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.

OVID
Breast Cancer Research
(Full text available: 1999 - present)

BioMed Central
Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness.

New England Journal of Medicine
CA: A Cancer Journal
(Full text available: 1950 - present)

American Cancer Society
Cancer Clinical Trials

National Cancer Institute
Cancer Prevention and Control

National Center for Chronic Disease Prevention & Health Promotion
Cancer Topics

National Cancer Institute
Center to Reduce Cancer Health Disparities

National Cancer Institute
Clinical Oncology Practice Guidelines

American Society of Clinical Oncology
Clinical Trials at Duke

Medical Center
Clinical Trials at WFU

Baptist Medical Center
ClinicalTrials.gov

ClinicalTrials.gov
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells

No Pub/Vend Assigned
Controversies in Hereditary Cancer Management

OVID
Diagnosis and management of adenocarcinoma in situ: A Society of Gynecologic Oncology evidence-based review and recommendations

No Pub/Vend Assigned
Effect of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers.

No Pub/Vend Assigned
Effect of taxane plus platinum regimens vs doxorubicin plus cisplatin as adjuvant chemotherapy for endometrial cancer at a high risk of progression: A randomized clinical trial

No Pub/Vend Assigned
Efficacy and Safety of Pembrolizumab in Combination With Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Ovarian Cancer A Phase 2 Nonrandomized Clinical Trial

JAMA Network
Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer

PubMed
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial

Elsevier
Endocrine Late Effects in Survivors of Cancer in Adolescence and Young Adulthood A Danish Population-Based Cohort Study

JAMA Network
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations -- Part I and Part II

American Board of Obstetrics and Gynecology
ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up.

OVID
Evidence of stage shift in women diagnosed with ovarian cancer during Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.

American Society of Clinical Oncology
Evidence-based consensus recommendations for colposcopy practice for cervical cancer prevention in the United States.

ABOG
Executive Summary of the Uterine Cancer Evidence Review Conference

American Journal of Obstetrics and Gynecology
Financial toxicity: A practical review for gynecologic oncology teams to understand and address patient-level financial burdens

Elsevier
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): A randomised controlled phase 3 trial

Elsevier
Hand-held Fan Airflow Stimulation Relieves Dyspnea in Lung Cancer Patients

No Pub/Vend Assigned
Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer.

No Pub/Vend Assigned
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.

JAMA
HPV Vaccination and the Risk of Invasive Cervical Cancer

New England Journal of Medicine
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

New England Journal of Medicine
The impact of cancer on subsequent chance of pregnancy: a population-based analysis.

Oxford University, UK
Impact of tamoxifen therapy on fertility in breast cancer survivors.

No Pub/Vend Assigned
Improved survival with bevacizumab in advanced cervical cancer

No Pub/Vend Assigned
Incidence of Suicide in Persons With Cancer

No Pub/Vend Assigned
Integrated genomic and molecular characterization of cervical cancer.

Nature
Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update.

No Pub/Vend Assigned
Interdisciplinary Management of Malignant Ovarian Tumors in the Pediatric and Adolescent Age Group

No Pub/Vend Assigned
Intraperitoneal chemotherapy: long-term outcomes revive a long-running debate [editorial]

No Pub/Vend Assigned
Journal of Thoracic Oncology
(Full text available: 2006 - present (embargo: 12m))

Elsevier
Journal Watch Online (free registration required to access some content)

New England Journal of Medicine
Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trial.

No Pub/Vend Assigned
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

New England Journal of Medicine
Long-term Follow-up After Endometrial Ablation in Finland: Cancer Risks and Later Hysterectomies

OVID
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

OVID
MedlinePlus - Cancer

MedlinePlus
MedlinePlus - Cancer Topics

MedlinePlus
medRxiv

Cold Spring Harbor Laboratory
Medscape Reference: Drugs, Diseases, Procedures

Medscape
Metformin reduces the risk of cancer in patients with type 2 diabetes An analysis based on the Korean National Diabetes Program Cohort

PMC
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

ASCO
Mutations in homologous recombination genes and outcomes in ovarian carcinoma patients in GOG 218: an NRG oncology/gynecologic oncology group study.

No Pub/Vend Assigned
National Cancer Institute

National Institutes of Health (NIH)
National Cancer Institute Complementary and Alternative Medicine

National Cancer Institute
National Comprehensive Cancer Network

National Comprehensive Cancer Network
National estimates of genetic testing in women with a history of breast or ovarian cancer.

ABOG
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.

No Pub/Vend Assigned
Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer.

New England Journal of Medicine
North Carolina Central Cancer Registry

State Center for Health Statistics
Olaparib plus bevacizumab as first-line maintenance in ovarian cancer

PubMed
Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial

ASCO
Oncologist
(Full text available: 1996 - present)

AlphMed Press
Oncology Nursing Society

Oncology Nursing Society
Options for Prevention and Management of Menstrual Bleeding in Adolescent Patients Undergoing Cancer Treatment

Wolters Kluwer Health
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

Elsevier
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update

No Pub/Vend Assigned
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline

ASCO
PDR.net

Thomson Healthcare
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

New England Journal of Medicine
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

New England Journal of Medicine
Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer

No Pub/Vend Assigned
Poly(ADP-Ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: ASCO Guideline Rapid Recommendation Update

No Pub/Vend Assigned
Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women

American Journal of Obstetrics and Gynecology
Predictive factors for post-operative respiratory infections after esophagectomy for esophageal cancer: outcome of randomized trial

PubMed Central
The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis

No Pub/Vend Assigned
PubMed MEDLINE

PubMed
Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II

No Pub/Vend Assigned
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study

Elsevier
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

New England Journal of Medicine
Randomized trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study.

PubMed
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

No Pub/Vend Assigned
RCA reversion mutations in circulating tumor DNA predict primary and acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma.

No Pub/Vend Assigned
Research & Innovation at UNC (look here for Clinical Trials info)

UNC Healthcare
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.

JAMA Network
Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.

BMJ
Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study

No Pub/Vend Assigned
The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.

Oxford University, UK
Screening for ovarian cancer: US Preventive Services Task Force Recommendation Statement.

US Preventative Services Task Force
Search Rxiv

No Pub/Vend Assigned
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer

PubMed
Soft Tissue and Uterine Leiomyosarcoma.

No Pub/Vend Assigned
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. ICON7 trial investigators.

No Pub/Vend Assigned
State Cancer Profiles

National Cancer Institute
Survival with Cemiplimab in Recurrent Cervical Cancer

New England Journal of Medicine
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial

No Pub/Vend Assigned
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer

New England Journal of Medicine
Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years

Elsevier
U.S. Preventive Services Task Force

Agency for Healthcare Research & Quality
Understanding Multiple Myeloma

No Pub/Vend Assigned
Using Bundled Interventions to Reduce Surgical Site Infection After Major Gynecologic Cancer Surgery

OVID
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial

Elsevier

"Oncology" (117 records)

Filter by Specialty

Filter by Resource Type